Treatment of patients with chemotherapy induced anaemia Silapo should be administered by the subcutaneous route to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dl (6.2 mmol/l).
Anaemiás (pl. hemoglobin- koncentráció ≤ 10 g/ dl (6, 8 mmol/ l) betegeknél a Silapo- t subcutan kell alkalmazni.